Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19

Khan Sharun^a, Kuldeep Dhama^{b c}✉, Shailesh Kumar Patel^c, Mamta Pathak^c, Ruchi Tiwari^d, Bhoj Raj Singh^e, Ranjit Sah^f, D. Katterine Bonilla‐Aldana^{g h}, Alfonso Javier Rodriguez-Morales^{g i j}✉, Hakan Leblebicioğlu^k

1. ^aDivision of Surgery, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, 243 122, Uttar Pradesh, India
2. ^bDivision of Pathology, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, 243 122, Uttar Pradesh, India. kdhama@rediffmail.com
3. ^cDivision of Pathology, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, 243 122, Uttar Pradesh, India
4. ^dDepartment of Veterinary Microbiology and Immunology, College of Veterinary Sciences, UP Pandit Deen Dayal Upadhayay Pashu Chikitsa Vigyan Vishwavidyalay Evum Go-Anusandhan Sansthan (DUVASU), Mathura, 281001, India
5. ^eDivision of Epidemiology, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, 243 122, Uttar Pradesh, India
6. ^fDepartment of Microbiology, Institute of Medicine, Tribhuvan University Teaching Hospital, Kathmandu, Nepal
7. ^gPublic Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnologica de Pereira, Pereira, Colombia
8. ^hSemillero de Zoonosis, Grupo de Investigación BIOECOS, Fundación Universitaria Autónoma de las Américas, Sede Pereira, Pereira, Risaralda, Colombia